These include regions of FTE exhibiting strong p53 immunostaining, reflective of TP53 mutations characteristic of HGSOCs, and tubal intraepithelial carcinomas (TICs), which are occult in situ adenocarcinomas [6], [7], [8]. This evidence concerns the gene TP53 and adenocarcinoma in situ.